Indivior has announced the launch of an authorised generic version of Suboxone Film (buprenorphine/naloxone) a combination medicine used to treat opioid use disorder, following a US court’s decision to open the market to generic competitors.
Novartis’ Sandoz unit will begin marketing the generic opioid use treatment in the US immediately.
English firm, Indivior has been battling generic drugmakers in trying to prevent Suboxone generics from entering the market for years.
